Exosomes have emerged as a central component of regenerative medicine due to their role in cell-to-cell communication. These nanoscale extracellular vesicles are naturally released by cells and carry a complex cargo of proteins, lipids, messenger RNA (mRNA), and microRNA (miRNA). This cargo reflects the biological activity of their parent cells and allows exosomes to influence surrounding cells by modulating signaling pathways, gene expression, and cellular behavior. As a result, much of the therapeutic interest in regenerative medicine has shifted toward the secretome—the signaling output of cells—rather than the cells themselves.

Compared to traditional cell-based approaches, exosomes offer several practical and biological advantages. Due to their small size and acellular nature, they are less likely to trigger immune recognition and can circulate more readily within the body’s microenvironments. Exosomes are also more stable than living cells and can be processed, stored, and handled with greater consistency. Their ability to interact with target cells and deliver bioactive signaling molecules has positioned them as a promising modality for supporting tissue environment modulation without relying on direct cell engraftment.

Exosomes are increasingly studied for their ability to support precision signaling within complex biological systems. By delivering specific molecular cues, they may help coordinate processes such as inflammatory response modulation, cellular repair signaling, and maintenance of tissue homeostasis. This has led to growing interest across multiple fields, including orthopedics, neurology, and integrative medicine. While research is ongoing, the unique combination of biological signaling capacity, scalability, and handling advantages continues to position exosomes as a leading focus in the evolution of regenerative medicine.